Comparative hepatoprotective efficacy of some anti-oxidants and prebiotics on experimentally induced hepatic fibrosis in rats

Zeinab Adel Mahmoud El-Gendy;

Abstract


Fibrosis represents a common outcome of almost all chronic liver diseases and leads to an impairment of liver function that requires medical intervention. The current study aimed at evaluating the potential anti- fibrotic activity of saccharomyces cervisciae cell wall extract (SCCWE) and carvacrol against thioacetamide (TAA)-induced liver fibrosis in rats (200mg/ kg b.w. i.p. twice weekly for 6 weeks) using ursodeoxycholic acid (UDCA) (20 mg/kg p.o.) as a reference anti-fibrotic product. SCCWE at two doses (50 and 100 mg/kg) and carvacrol at two doses (25 and 50 mg/ kg p.o.) significantly ameliorated the rise in serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma glutamide transferase (GGT), total bilirubin (TB) and direct bilirubin (DB) and increased total protein (TP) and albumin level. SCCWE significantly reduced glutathione depletion (GSH), nitric oxide (NOX) and malondialdehyde (MDA) accumulation in liver tissue. Its anti-oxidant effects appeared by affecting markers of stress found in the cell as nuclear erythroid factor -2 (Nrf-2) by significantly restoring its content. Its anti-inflammatory effects were confirmed by observing the decreasing of nuclear factor-кB (NF-кB), interleukin-1β (IL-1β) and inducible nitric oxide synthetase (iNOS) content. The anti-fibrotic effects of them were explored by assessing fibrosis related markers as they significantly reduced autotaxin (ATX), transforming growth factor β (TGF-β) and thioredoxin (Trx). Their administration significantly decreased matrix metalloproteinase-3 and 9 (MMP-3 and 9). Furthermore, they also decreased alpha smooth muscle actin (α-SMA) and caspase-3 as assessed immunohistochemically those results were similar to that of the standard drug UDCA. Overall result showed that SCCWE and carvacrol protect against TAA-induced liver fibrosis in rats, so they can be ascribed as a protecting natural materials from liver fibrosis.


Other data

Title Comparative hepatoprotective efficacy of some anti-oxidants and prebiotics on experimentally induced hepatic fibrosis in rats
Other Titles دراسة مقارنة عن الفعالية الوقائية لبعض مضادات الأكسدة والبريبيوتكس على التليف الكبدي المستحدث تجريبيا في الجرذان
Authors Zeinab Adel Mahmoud El-Gendy
Issue Date 2021

Attached Files

File SizeFormat
BB10584.pdf1.83 MBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 3 in Shams Scholar
downloads 1 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.